Table of contents
Acromegaly
What's new
Updated 2021 ESE guidelines for the management of acromegaly during pregnancy.
Background
Overview
Guidelines
Key sources
Classification and risk stratification
Diagnostic investigations
More topics in this section
GH
Brain imaging
Visual field testing
Evaluation of thyroid abnormalities
Screening for vertebral fractures
Screening for comorbidities
Screening for cancer
Medical management
More topics in this section
Indications for medical therapy
Therapeutic targets
Somatostatin receptor ligands
GH receptor antagonists
Combination therapy
Dopamine agonists
Temozolomide
Pituitary hormone replacement
Management of comorbidities
Therapeutic procedures
Perioperative care
Surgical interventions
More topics in this section
Surgical debulking
Specific circumstances
More topics in this section
Pregnant patients (evaluation)
Pregnant patients (management)
Pregnant patients (monitoring)
Pregnant patients (delivery and breastfeeding)
Patients with gigantism
Follow-up and surveillance
More topics in this section
Serial laboratory assessment (after radiotherapy)
Serial imaging assessment (after surgery)
Serial imaging assessment (on medical therapy)
Management of postoperative residual disease (repeat surgery)
Management of postoperative residual disease (radiotherapy)
Management of incomplete treatment response